Journal Information
Most often read
580
Possible role of 99mTC-Sestamibi scintigraphy in the follow-up of Kawasaki-like disease related to SARS-CoV-2Nicoletta Urbano, Manuel Scimeca, Rita Bonfiglio, Elena Bonanno, Orazio Schillaci
Rev Esp Med Nucl Imagen Mol. 2022;41:201
580
378
18F-Choline PET/MRI limphadenopathy related to SARS-CoV-2 vaccineJ.R. Garcia, A. Compte, P. Bassa, S. Mourelo, S. Ortiz, E. Riera
Rev Esp Med Nucl Imagen Mol. 2022;41 Supl 1:S51-S52
378
300
Diagnostic methodology in labelled leukocyte scan for prosthetic / non-prosthetic osteoarticular infection: Visual or semi-quantitative analysis? One- or two-day protocol?Edel Noriega-Álvarez, Ana M. García Vicente, Francisco J. Pena Pardo, Germán A. Jiménez Londoño, Mariano Amo-Salas, Ana M. Benítez Segura, María T. Bajén Lázaro, Jaime Mora Salvadó, ... Ángel M. Soriano Castrejón
Rev Esp Med Nucl Imagen Mol. 2022;41:17-27
300
241
Brain perfusion SPECT in Alice in Wonderland syndromeP. Oliván-Sasot, C. Ipiens-Escuer, A.C. Orozco-Molano, H. Azzi, L. Camacho-Berne, A. Tembl-Ferrairo
Rev Esp Med Nucl Imagen Mol. 2022;41 Supl 1:S62-S63
241
213
PET co-registered with MRI imaging of anti-NMDAR encephalitis patient with SARS-CoV-2 infectionA. Mestre Fusco, B. Beltrán Mármol, G. Álvarez Bravo, N. Ferran Sureda, M. Negre Busó, A. Rubió Rodríguez
Rev Esp Med Nucl Imagen Mol. 2022;41 Supl 1:S46-S47
213
154
Implementation of the failure modes and effects analysis in a Hospital Radiopharmacy UnitI. Romero-Zayas, F. Campos Añón, M. Santos Virosta, J. Cordón del Pozo, C. Santos Montero, A. Niñerola Baizán, D. Fuster
Rev Esp Med Nucl Imagen Mol. 2022;41:300-10
154
74
Imagenomics. Findings in PET with 68Ga-DOTA-TOC associated with the detection of the mutation of the succinate dehydrogenase B (SDHB) gene in the screening of hereditary pheochromocytoma/paragangliomaS. Ortiz Banguera, O. Busquets Carrera, M. Ysamat, J.M. Gonzalez, E. Riera Gil, J.R. Garcia
Rev Esp Med Nucl Imagen Mol. 2022;41:268-70
74
33
Failure of scintigraphy lymphatic mapping in endometrial cancer. Causes and solutionsWilson Rafael Martínez Bravo, Ana María García Vicente, Edel Noriega Álvarez, Beatriz González García, Carlos López-de la Manzanara, José Manuel Cordero García, Ángel Soriano Castrejón
Rev Esp Med Nucl Imagen Mol. 2022;41:78-85
33
33
Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATES. Prado-Wohlwend, J.C. Bernal-Vergara, A. Utrera-Costero, J.R. Cañón-Sánchez, M. Agudelo-Cifuentes, P. Bello-Arques
Rev Esp Med Nucl Imagen Mol. 2022;41:55-65
33
32
Update on the diagnosis of encephalitisJ. Arbizu, J. Gállego Pérez-Larraya, A. Hilario, A. Gómez Grande, S. Rubí, V. Camacho
Rev Esp Med Nucl Imagen Mol. 2022;41:247-57
32
27
The value of parathyroid scintigraphy on lesion detection in patients with normocalcemic primary hyperparathyroidismSerkan Gungor, Fuat Dede, Bulent Can, Havva Keskin, Mustafa Aras, Tunc Ones, Tanju Yusuf Erdil, Halil Turgut Turoglu
Rev Esp Med Nucl Imagen Mol. 2022;41:86-90
27
27
FDG PET/CT findings of a child with extramedullary relapsed ALL after allogeneic bone marrow transplantationNilufer Yildirim, Dilek Kacar
Rev Esp Med Nucl Imagen Mol. 2022;41:199-200
27
23
Interventional nuclear medicine's contribution to molecularly targeted precision surgeryR. Valdés Olmos, S. Vidal-Sicart, S. Fuertes Cabero, E. Goñi Gironés, P. Paredes
Rev Esp Med Nucl Imagen Mol. 2022;41:179-87
23
22
The role of PSMA radioligands in the diagnosis and treatment of prostate carcinomaM. Rodríguez-Fraile, P. Tamayo Alonso, J.J. Rosales, María de Arcocha-Torres, A.P. Caresia-Aróztegui, María Puig Cózar-Santiago, Javier Orcajo-Rincon, Marc Simó Perdigó, ... on behalf of the Oncology Working Group of the Spanish Society of Nuclear Medicine and Molecular Imaging
Rev Esp Med Nucl Imagen Mol. 2022;41:126-35
22
19
Different adenocarcinomas subtypes present different 18-FDG PET/TC and 68Ga-DOTATOC uptake: An unique caseMarco Chiappetta, Alessandra Cancellieri, Carolina Sassorossi, Lucio Calandriello, Fabrizio Cocciolillo, Filippo Lococo
Rev Esp Med Nucl Imagen Mol. 2022;41 Supl 1:S12-S14
19
18
Increasing the confidence of 18F-Florbetaben PET interpretations: Machine learning quantitative approximationAna María García Vicente, María Jesús Tello Galán, Francisco José Pena Pardo, Mariano Amo-Salas, Beatriz Mondejar Marín, Santiago Navarro Muñoz, Ignacio Rueda Medina, Víctor Manuel Poblete García, ... Ángel Soriano Castrejón
Rev Esp Med Nucl Imagen Mol. 2022;41:153-63
18
17
Clinical application of [18F]FDG PET/CT in follicular lymphomaA. Díaz-Silván, L.F. Otón-Sánchez, A.P. Caresia-Aróztegui, M. del Puig Cózar-Santiago, J. Orcajo-Rincón, M. de Arcocha-Torres, R.C. Delgado-Bolton, D. Cabello-García
Rev Esp Med Nucl Imagen Mol. 2022;41:202-12
17
16
Artificial Intelligence and Nuclear Medicine. Today is already the futureJuan Antonio Vallejo Casas, Ester Rodríguez-Caceres
Rev Esp Med Nucl Imagen Mol. 2022;41:1-2
16
15
Budd-Chiari syndrome secondary to tumor thrombus of hepatocellular carcinoma detected by 18F-FDG PET/CTSelin Kesim, Salih Ozguven
Rev Esp Med Nucl Imagen Mol. 2022;41 Supl 1:S15-S16
15
15
Staging of primary cardiac lymphoma through 18F-FDG PET/CT with extrathoracic extensionP. Romero Fernández, C.G. Wakfie-Corieh, J. Carla-Villa, J.C. Gómez Polo, M.N. Cabrera Martín
Rev Esp Med Nucl Imagen Mol. 2022;41:266-7
15